ARVEE — Arvee Laboratories (India) Balance Sheet
0.000.00%
- IN₹1.78bn
- IN₹1.74bn
- IN₹384.87m
Annual balance sheet for Arvee Laboratories (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 86.4 | 31.1 | 8.92 | 18.7 | 49.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 78.8 | 122 | 123 | 61.3 | 84.3 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 256 | 222 | 216 | 170 | 197 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 147 | 148 | 142 | 153 | 160 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 410 | 387 | 387 | 386 | 376 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 183 | 133 | 88.4 | 71.3 | 38.3 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 196 | 147 | 106 | 94.5 | 63.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 214 | 239 | 281 | 291 | 313 |
| Total Liabilities & Shareholders' Equity | 410 | 387 | 387 | 386 | 376 |
| Total Common Shares Outstanding |